These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15127317)

  • 21. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.
    Browne DL; Gancher ST; Nutt JG; Brunt ER; Smith EA; Kramer P; Litt M
    Nat Genet; 1994 Oct; 8(2):136-40. PubMed ID: 7842011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures.
    Ishida S; Sakamoto Y; Nishio T; Baulac S; Kuwamura M; Ohno Y; Takizawa A; Kaneko S; Serikawa T; Mashimo T
    Brain Res; 2012 Jan; 1435():154-66. PubMed ID: 22206926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene.
    D'Adamo MC; Gallenmüller C; Servettini I; Hartl E; Tucker SJ; Arning L; Biskup S; Grottesi A; Guglielmi L; Imbrici P; Bernasconi P; Di Giovanni G; Franciolini F; Catacuzzeno L; Pessia M; Klopstock T
    Front Physiol; 2014; 5():525. PubMed ID: 25642194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization of a novel mutation in KCNA1 in episodic ataxia type 1 associated with epilepsy.
    Spauschus A; Eunson L; Hanna MG; Kullmann DM
    Ann N Y Acad Sci; 1999 Apr; 868():442-6. PubMed ID: 10414318
    [No Abstract]   [Full Text] [Related]  

  • 25. Episodic ataxia type-1 mutations in the Kv1.1 potassium channel display distinct folding and intracellular trafficking properties.
    Manganas LN; Akhtar S; Antonucci DE; Campomanes CR; Dolly JO; Trimmer JS
    J Biol Chem; 2001 Dec; 276(52):49427-34. PubMed ID: 11679591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of kv1 potassium channels in spreading acidification and depression in the cerebellar cortex.
    Chen G; Gao W; Reinert KC; Popa LS; Hendrix CM; Ross ME; Ebner TJ
    J Neurophysiol; 2005 Aug; 94(2):1287-98. PubMed ID: 15843481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Episodic ataxia type 1 without episodic ataxia: the diagnostic utility of nerve excitability studies in individuals with KCNA1 mutations.
    Tan SV; Wraige E; Lascelles K; Bostock H
    Dev Med Child Neurol; 2013 Oct; 55(10):959-62. PubMed ID: 23909822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.
    Graves TD; Rajakulendran S; Zuberi SM; Morris HR; Schorge S; Hanna MG; Kullmann DM
    Neurology; 2010 Jul; 75(4):367-72. PubMed ID: 20660867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermia.
    Mestre TA; Manole A; MacDonald H; Riazi S; Kraeva N; Hanna MG; Lang AE; Männikkö R; Yoon G
    Neurogenetics; 2016 Oct; 17(4):245-249. PubMed ID: 27271339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia.
    Tristán-Clavijo E; Scholl FG; Macaya A; Iglesias G; Rojas AM; Lucas M; Castellano A; Martinez-Mir A
    Mov Disord; 2016 Nov; 31(11):1743-1748. PubMed ID: 27477325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Spectrum of
    Paulhus K; Ammerman L; Glasscock E
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Spinocerebellar ataxias in infancy: pathogenesis of potassium and calcium channels' diseases, clinical features and therapeutical approach].
    Bozzola E; Savasta S; Peruzzi C; Bozzola M; Bona G
    Minerva Pediatr; 2007 Apr; 59(2):149-56. PubMed ID: 17404565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in
    Lauxmann S; Sonnenberg L; Koch NA; Bosselmann C; Winter N; Schwarz N; Wuttke TV; Hedrich UBS; Liu Y; Lerche H; Benda J; Kegele J
    Front Neurol; 2021; 12():703970. PubMed ID: 34566847
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K(+) channel function.
    D'Adamo MC; Imbrici P; Sponcichetti F; Pessia M
    FASEB J; 1999 Aug; 13(11):1335-45. PubMed ID: 10428758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1.
    Imbrici P; Gualandi F; D'Adamo MC; Masieri MT; Cudia P; De Grandis D; Mannucci R; Nicoletti I; Tucker SJ; Ferlini A; Pessia M
    Neuroscience; 2008 Dec; 157(3):577-87. PubMed ID: 18926884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into the pathogenesis and therapeutics of episodic ataxia type 1.
    D'Adamo MC; Hasan S; Guglielmi L; Servettini I; Cenciarini M; Catacuzzeno L; Franciolini F
    Front Cell Neurosci; 2015; 9():317. PubMed ID: 26347608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.
    Yuan H; Yuan H; Wang Q; Ye W; Yao R; Xu W; Liu Y
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1434. PubMed ID: 32705822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel CACNA1A mutation causes febrile episodic ataxia with interictal cerebellar deficits.
    Subramony SH; Schott K; Raike RS; Callahan J; Langford LR; Christova PS; Anderson JH; Gomez CM
    Ann Neurol; 2003 Dec; 54(6):725-31. PubMed ID: 14681882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mouse model of episodic ataxia type-1.
    Herson PS; Virk M; Rustay NR; Bond CT; Crabbe JC; Adelman JP; Maylie J
    Nat Neurosci; 2003 Apr; 6(4):378-83. PubMed ID: 12612586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.
    Manville RW; Abbott GW
    J Pharmacol Exp Ther; 2020 Jun; 373(3):391-401. PubMed ID: 32217768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.